Trial Profile
Randomized Phase II Study of Capecitabine With or Without Oxaliplatin As First-line Treatment for Elderly or Fragile Patients With Metastatic Colorectal Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Aug 2012
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Oxaliplatin (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 28 Aug 2012 New trial record
- 02 Aug 2012 Results published in the American Journal of Clinical Oncology.